95% of Certified Health IT Developers Met ONC Cures Act Deadline

95% of Certified Health IT Developers Met ONC Cures Act Deadline

– More than 95 percent of certified health IT developers met the Cures Act Final Rule compliance deadline to provide customers with new technology, according to an ONC HealthITBuzz blog post. The Cures Act Final Rule mandated many changes to the Certification Program, including four updates set to have long-lasting interoperability impacts on patients, clinicians, and developers. ONC Certified Health IT developers must: Advance interoperability for patients and providers through the use of FHIR-based application programming interfaces (APIs);Enable patients, providers, and other stakeholders to have access to consistent data elements represented in at least version one of the United States Core…

Continue Reading
Mining EHR data to understand documentation burnout

Mining EHR data to understand documentation burnout

The Office of the National Coordinator for Health Information found that hospitals’ access and analysis of documentation data in electronic health records has increased over the past five years, but gaps in access and use remain for some hospitals.WHY IT MATTERSData from EHRs can track the time clinicians spend documenting and carrying out certain tasks. To measure physician burden on a national scale, ONC analyzed four waves of a nationally representative survey of U.S. non-federal acute care hospitals.
Published in January, in the special health IT issue of the American Journal of Managed Care, Trends in Electronic Health Record Capabilities for Tracking…

Continue Reading
New York approves AI-driven breast cancer diagnostic

New York approves AI-driven breast cancer diagnostic

With Clinical Laboratory Evaluation Program assay validation, the company’s Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples.WHY IT MATTERS
Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible.
“Consistent with our mission of improving healthcare, PDxBr has shown to be an effective prognostic tool to further improve risk stratification over current histopathology methods,” said Wayne Brinster, CEO of PreciseDx, in an announcement.
The company says the AI technology has now proven its ability to enhance invasive breast cancer pathology interpretation with objective, quantifiable and accurate…

Continue Reading
UChicago to launch accelerator for AI and data science companies

UChicago to launch accelerator for AI and data science companies

The University of Chicago this week announced the creation of Transform, an accelerator for early-stage technology companies focused on data science and artificial intelligence.WHY IT MATTERSThe new program – which is part of the Deep Tech Ventures initiative at the UChicago’s Polsky Center for Entrepreneurship and Innovation – aims to offer a wide array of support to startups: access to business and technical training, industry mentorship, venture capital connections, and funding opportunities
Transform is seeking two cohorts of as many as 10 companies each. Candidates should be focused on information technologies and data science: AI and machine learning, data engineering, analytics and…

Continue Reading